The IVD Contract Manufacturing Market is projected to grow from USD 21.38 billion in 2025 to USD 56.94 billion by 2034, at a CAGR of 11.50%. Growth is fueled by outsourcing efficiency, technological convergence, and rising demand for personalized and point-of-care diagnostics. North America leads, with Asia-Pacific expanding fastest.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: IVD Contract Manufacturing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. IVD Contract Manufacturing Market, by Device Type
8.1.1 IVD Equipment
8.1.1.1. Market Revenue and Forecast
8.1.2. IVD Consumables
8.1.2.1. Market Revenue and Forecast
9.1. IVD Contract Manufacturing Market, by Technology
9.1.1. Immunoassay
9.1.1.1. Market Revenue and Forecast
9.1.2. Clinical Chemistry
9.1.2.1. Market Revenue and Forecast
9.1.3. Molecular Diagnostics
9.1.3.1. Market Revenue and Forecast
9.1.4. Microbiology
9.1.4.1. Market Revenue and Forecast
9.1.5. Hematology
9.1.5.1. Market Revenue and Forecast
9.1.6. Coagulation & Hemostasis
9.1.6.1. Market Revenue and Forecast
9.1.7. Others
9.1.7.1. Market Revenue and Forecast
10.1. IVD Contract Manufacturing Market, by Service Type
10.1.1. Manufacturing Services
10.1.1.1. Market Revenue and Forecast
10.1.2. Assay Development Services
10.1.2.1. Market Revenue and Forecast
10.1.3. Other Services
10.1.3.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Device Type
11.1.2. Market Revenue and Forecast, by Technology
11.1.3. Market Revenue and Forecast, by Service Type
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Device Type
11.1.4.2. Market Revenue and Forecast, by Technology
11.1.4.3. Market Revenue and Forecast, by Service Type
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Device Type
11.1.5.2. Market Revenue and Forecast, by Technology
11.1.5.3. Market Revenue and Forecast, by Service Type
11.2. Europe
11.2.1. Market Revenue and Forecast, by Device Type
11.2.2. Market Revenue and Forecast, by Technology
11.2.3. Market Revenue and Forecast, by Service Type
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Device Type
11.2.4.2. Market Revenue and Forecast, by Technology
11.2.4.3. Market Revenue and Forecast, by Service Type
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Device Type
11.2.5.2. Market Revenue and Forecast, by Technology
11.2.5.3. Market Revenue and Forecast, by Service Type
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Device Type
11.2.6.2. Market Revenue and Forecast, by Technology
11.2.6.3. Market Revenue and Forecast, by Service Type
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Device Type
11.2.7.2. Market Revenue and Forecast, by Technology
11.2.7.3. Market Revenue and Forecast, by Service Type
11.3. APAC
11.3.1. Market Revenue and Forecast, by Device Type
11.3.2. Market Revenue and Forecast, by Technology
11.3.3. Market Revenue and Forecast, by Service Type
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Device Type
11.3.4.2. Market Revenue and Forecast, by Technology
11.3.4.3. Market Revenue and Forecast, by Service Type
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Device Type
11.3.5.2. Market Revenue and Forecast, by Technology
11.3.5.3. Market Revenue and Forecast, by Service Type
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Device Type
11.3.6.2. Market Revenue and Forecast, by Technology
11.3.6.3. Market Revenue and Forecast, by Service Type
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Device Type
11.3.7.2. Market Revenue and Forecast, by Technology
11.3.7.3. Market Revenue and Forecast, by Service Type
11.4. MEA
11.4.1. Market Revenue and Forecast, by Device Type
11.4.2. Market Revenue and Forecast, by Technology
11.4.3. Market Revenue and Forecast, by Service Type
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Device Type
11.4.4.2. Market Revenue and Forecast, by Technology
11.4.4.3. Market Revenue and Forecast, by Service Type
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Device Type
11.4.5.2. Market Revenue and Forecast, by Technology
11.4.5.3. Market Revenue and Forecast, by Service Type
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Device Type
11.4.6.2. Market Revenue and Forecast, by Technology
11.4.6.3. Market Revenue and Forecast, by Service Type
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Device Type
11.4.7.2. Market Revenue and Forecast, by Technology
11.4.7.3. Market Revenue and Forecast, by Service Type
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Device Type
11.5.2. Market Revenue and Forecast, by Technology
11.5.3. Market Revenue and Forecast, by Service Type
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Device Type
11.5.4.2. Market Revenue and Forecast, by Technology
11.5.4.3. Market Revenue and Forecast, by Service Type
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Device Type
11.5.5.2. Market Revenue and Forecast, by Technology
11.5.5.3. Market Revenue and Forecast, by Service Type
12.1. Thermo Fisher Scientific Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Siemens Healthineers AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Danaher Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Roche Diagnostics
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Ortho Clinical Diagnostics
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Abbott Laboratories
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bio-Rad Laboratories, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sysmex Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Quidel Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. BioMérieux SA
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description